Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Albemarle Corporation Q4 2025 Earnings Call - Idles Kemerton, raises lithium demand outlook and targets positive free cash flow
Albemarle closed 2025 with stronger-than-expected volumes and cash generation, but management is fighting structural cost gaps and shifting the portfolio to protect margins. The company reported $1.4 ...
- Q4 2025 results: net sales $1.4 billion, up 16% year over year, adjusted EBITDA $269 million, up 7% year over year; full-year net sales $5.1 billion and adjusted EBITDA $1.1 billion.
- Management achieved approximately $450 million of run-rate cost and productivity improvements in 2025, and is targeting an additional $100 million to $150 million of savings in 2026.
- Capital discipline: 2025 CapEx cut by about 65% year over year, 2026 sustaining CapEx guided essentially flat versus 2025 after the Ketjen sale, and management prioritizes lower sustaining spend and selective, fast-payback growth projects.
- +13 more takeaways
Noble Corporation Fourth Quarter 2025 Earnings Call - $7.5B Backlog Paves Path to ~$1.3B EBITDA Run-Rate by H2 2027
Noble closed 2025 with stronger-than-expected commercial momentum, booking backlog to $7.5 billion and delivering adjusted EBITDA of $1.1 billion for the year. Q4 adjusted EBITDA was $232 million, fre...
- Backlog increased to $7.5 billion as of Feb 11, 2026, underpinning forward revenue and earnings visibility.
- Full year 2025 adjusted EBITDA was roughly $1.1 billion, with Q4 adjusted EBITDA of $232 million and full-year free cash flow of $454 million.
- Board declared a $0.50 per share quarterly dividend, and Noble returned $80 million of capital in Q4.
- +12 more takeaways
Euronet Worldwide Fourth Quarter 2025 Earnings Call - Tough Quarter, But Management Sees 10%-15% EPS Growth in 2026 Driven by Digital Push and EFT Strength
Euronet reported a challenging Q4 2025, hit by immigration-policy uncertainty and economic stress among lower-income consumers that pressured money transfer and epay. Despite that, the company posted ...
- Q4 2025 was one of the more challenging operating quarters in recent memory, with immigration policy uncertainty and economic stress weighing most heavily on money transfer and epay.
- Management remains confident, forecasting adjusted EPS growth of 10% to 15% for 2026 and pointing to multiple levers to drive upside as volumes normalize and investments scale.
- Q4 adjusted EPS was $2.39; full-year adjusted EPS was $9.61, representing the company’s fifth consecutive year of double-digit adjusted EPS growth.
- +15 more takeaways
Conduent Q4 2025 Earnings Call - New CEO Launches Turnaround: Speed, Cost Cuts, Portfolio Sales to Restore Free Cash Flow
Newly installed CEO Harsha Agadi used his first public quarterly call to frame Conduent as a turnaround. He laid out six immediate priorities: move faster, apply strict capital discipline, cut corpora...
- New CEO Harsha Agadi has been on the job less than 30 days and declared Conduent a turnaround, announcing six priorities: speed, financial discipline, cost reduction, portfolio rationalization, pipeline conversion, and organizational simplification.
- Qualified ACV pipeline stands at $3.2 billion, up 4% year-over-year, and management emphasized converting pipeline to revenue rather than just building it.
- Quarterly new business ACV was $152 million, one of the strongest quarters recently, and full year 2025 new business ACV was $517 million, up 6% versus 2024.
- +14 more takeaways
AB InBev Full Year 2025 Earnings Call - Strategy Delivered EPS, Margin and Cash Growth Despite Volume Weakness
AB InBev closed 2025 with a familiar-but-uneven picture: volumes lagged, but disciplined revenue management, premiumization and productivity drove dollar EPS, EBITDA and margin expansion. The group re...
- Company delivered another year of dollar EPS growth, with underlying EPS of $3.73, up 6% in U.S. dollars and 9.4% in constant currency.
- EBITDA increased 4.9% year-over-year and margins expanded by 101 basis points, driven by disciplined revenue management and productivity gains.
- Free cash flow stayed around the prior-year level of $11.3 billion, enabling $3.2 billion of completed buybacks, a further $6 billion buyback program in execution, and a proposed final dividend that, combined with the interim dividend, raises payouts 15% year-over-year.
- +12 more takeaways
SCI Fourth Quarter 2025 Earnings Call - Insurance Shift Increases GA Revenue, Pressures Near-Term Margins; 2026 EPS Guide $4.05-$4.35
SCI closed 2025 with modest top-line gains, stronger cash flow, and an operational pivot that will shape 2026. Q4 adjusted EPS was $1.14, up 8% year over year, and full-year adjusted EPS was $3.85, up...
- Q4 2025 adjusted EPS was $1.14, up 8% from $1.06 a year earlier; full-year adjusted EPS was $3.85, up 9% versus 2024.
- 2026 normalized EPS guidance range is $4.05-$4.35, midpoint $4.20, implying 5%-13% growth, with management midpoint assumptions focused on sales momentum and cost control.
- Adjusted operating cash flow for full-year 2025 was $966 million; Q4 adjusted operating cash flow was $213 million, above guidance.
- +16 more takeaways
IFF Q4 and Full Year 2025 Earnings Call - Food Ingredients Sale Launched, Focus Shifts to High-Value Taste, Scent and Health
IFF closed 2025 with steady execution but a clear strategic pivot. Q4 revenue was nearly $2.6 billion, up 1% year over year, and EBITDA was $437 million, up 7% with margin expansion to 16.9%. The comp...
- IFF launched a formal, competitive sale process for its food ingredients business two weeks ago, after earlier divestitures of Pharma Solutions, Nitrocellulose, and Renee Laurent, and an agreement to sell soy crush, concentrates and lecithin to Bunge expected by April.
- Q4 revenue was nearly $2.6 billion, up 1% year over year against a 6% prior-year comparable; two-year average sales growth was about 4%.
- Q4 EBITDA totaled $437 million, up 7% year over year, and consolidated EBITDA margin expanded 90 basis points to 16.9%.
- +11 more takeaways
Pilgrim's Pride Q4 FY2025 Earnings Call - Branded momentum and heavy CapEx to blunt regional weakness
Pilgrim’s Pride closed fiscal 2025 with $18.5 billion in revenue and $2.27 billion of Adjusted EBITDA, highlighting momentum in branded prepared foods, led by Just BARE, and operational gains in the U...
- Fiscal 2025 revenue $18.5 billion; Adjusted EBITDA $2.27 billion, with an Adjusted EBITDA margin around 12.3% for the year.
- Q4 2025 net revenue $4.52 billion; management reported Q4 Adjusted EBITDA of $415.1 million and a 9.2% margin.
- U.S. business: FY net revenue $11.0 billion; U.S. Adjusted EBITDA $1.63 billion and a 14.8% margin, driven by fresh retail, QSR wins, and Big Bird operational improvements.
- +12 more takeaways
Materion Fourth Quarter 2025 Earnings Call - Quality Pause Hits Q4 but Semiconductor and Optics Momentum Powers 2026 Upside
Materion closed 2025 with a messy but fixable finale. A control failure in Precision Clad Strip forced a temporary shutdown of two facilities, subtracting from Q4 sales and cash flow. Excluding that e...
- Precision Clad Strip quality event halted production at two facilities in Q4 after a control failure produced non-conforming material discovered by the customer, temporarily stopping shipments and receipts.
- Management implemented root-cause fixes and a revised, more robust plant-wide quality system, customer visits occurred, and both facilities were brought back online late in the quarter and are ramping into Q1.
- Excluding the clad strip event, Q4 organic Value-Added Sales grew 7% year-over-year; overall Q4 Value-Added Sales were $253.9 million (excluding pass-through precious metals).
- +12 more takeaways
Rollins, Inc. Fourth Quarter 2025 Earnings Call - Recurring Growth Holds at 7%+, One-Time Sales Hit by Weather; 2026 Organic Guide 7%-8%
Rollins closed 2025 at $3.8 billion in revenue with double-digit revenue, earnings, and cash flow growth for the year, even as Q4 softened. Management pins the weakness to early winter weather in the ...
- Rollins reached $3.8 billion in revenue for fiscal 2025 and delivered double-digit revenue, earnings, and cash flow growth for the year.
- Organic growth for 2025 was 6.9% for the full year; management anchors 2026 organic guidance at 7%-8% plus 2%-3% from M&A.
- Recurring revenue and ancillary services, which represent over 80% of revenue, grew above 7% in Q4 and for the year, and are the primary metric management uses to judge health.
- +12 more takeaways